Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Serious infection is a concern for patients with psoriasis receiving biologic therapies. We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic therapies in a propensity score-weighted Cox proportional hazards mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiu, Zenas Z.N., Smith, Catherine H., Ashcroft, Darren M., Lunt, Mark, Walton, Shernaz, Murphy, Ruth, Reynolds, Nick J., Ormerod, Anthony D., Griffiths, Christopher E.M., Warren, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832757/
https://www.ncbi.nlm.nih.gov/pubmed/29054603
http://dx.doi.org/10.1016/j.jid.2017.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832757/
https://www.ncbi.nlm.nih.gov/pubmed/29054603
http://dx.doi.org/10.1016/j.jid.2017.10.005

Ejemplares similares